WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013053206) QUINAZOLINE DERIVATIVES AS KINASES INHIBITORS AND METHODS OF USE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/053206    International Application No.:    PCT/CN2012/001371
Publication Date: 18.04.2013 International Filing Date: 12.10.2012
IPC:
C07D 403/12 (2006.01), C07D 405/14 (2006.01), C07D 413/12 (2006.01), C07D 413/14 (2006.01), A61K 31/517 (2006.01), A61K 31/5377 (2006.01), A61K 31/55 (2006.01), A61K 31/551 (2006.01), A61K 31/553 (2006.01), A61P 43/00 (2006.01), A61P 35/00 (2006.01)
Applicants: TELIGENE LTD [CN/CN]; 218 Xinghu St., A1 North Building, Second Floor, D33,Suzhou Industrial Park Suzhou, Jiangsu 215123 (CN) (For All Designated States Except US).
ZHANG, Dawei [US/US]; (US) (US only)
Inventors: ZHANG, Dawei; (US)
Agent: ADVANCE CHINA I.P. LAW OFFICE; Suite 918-920, 9/F Dongshan Plaza, No. 69 Xianlie Central Road Guangzhou, Guangdong 510095 (CN)
Priority Data:
61/627,359 12.10.2011 US
Title (EN) QUINAZOLINE DERIVATIVES AS KINASES INHIBITORS AND METHODS OF USE THEREOF
(FR) DÉRIVÉS DE QUINAZOLINE EN TANT QU'INHIBITEURS DE KINASES ET LEURS PROCÉDÉS D'UTILISATION
Abstract: front page image
(EN)Disclosed are quinazolines of formula (I), pharmaceutically acceptable salts, solvates and hydrates thereof. The compounds have protein kinases inhibitory activities and are expected to be useful for the treatment of protein kinases mediated diseases and conditions.
(FR)L'invention concerne des quinazolines de formule (I), des sels, solvates et hydrates pharmaceutiquement acceptables de ceux-ci. Les composés ont des activités inhibitrices de protéines kinases et sont prévus pour servir au traitement de maladies et d'états à médiation par des protéines kinases.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)